Cleared Traditional

K942113 - CARBON DIOXIDE ANALYZER (MODEL CD-3A)

K942113 is an FDA 510(k) clearance for CARBON DIOXIDE ANALYZER (MODEL CD-3A), manufactured by Ametek, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 290-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1995
Decision
290d
Days
Class 2
Risk

K942113 is an FDA 510(k) clearance for the CARBON DIOXIDE ANALYZER (MODEL CD-3A). Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Ametek, Inc. (Pittsburgh, US). The FDA issued a Cleared decision on February 16, 1995 after a review of 290 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K942113

510(k) Number K942113 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 1994
Decision Date February 16, 1995
Days to Decision 290 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
150d slower than avg
Panel avg: 140d · This submission: 290d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 306
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K942113.
SIDESTREAM PUMP PLUG-IN MODULE OF COMPONENT MONITORING SYSTEM
K943389 · Hewlett-Packard Co. · Mar 1995
HANDYPACK 911SC
K944541 · Pace Tech, Inc. · Feb 1995
CAPNOSAT
K942849 · Spegas Industries, Ltd. · Feb 1995
DISPOSABLE GAS SAMPLING LINES
K946044 · Catheter Research, Inc. · Dec 1994
9100 MUTIGAS MONITOR
K941971 · Bci Intl., Inc. · Nov 1994
CAPNOCHECK
K941982 · Bci, Inc. · Oct 1994